Company Filing History:
1 out of 832,880 Years Active: 2011
Title: Rafael de Llorens: Innovator in Cancer Diagnostics
Introduction
Rafael de Llorens is a prominent inventor located in Banyoles, Spain. With a focus on advancing cancer diagnostics, he has made significant contributions through his innovative work in glycosylation markers. His pioneering research aims to improve how cancer is diagnosed and monitored, providing invaluable tools for the medical community.
Latest Patents
Rafael de Llorens holds a patent for his invention titled "Glycosylation markers for cancer diagnosing and monitoring." This innovative patent describes a method for identifying and quantifying glycosylation markers of cancer using quantitative HPLC analysis of glycans released from unpurified glycoproteins. His approach allows for the detection of native glycans or their digestion products, facilitating the diagnosis and monitoring of cancer in subjects. The methods outlined in his patent also open pathways for identifying glycoprotein biomarkers that carry these glycosylation markers, thereby enhancing diagnostic accuracy.
Career Highlights
During his career, Rafael de Llorens has made remarkable strides in the field of cancer research. His patent showcases his commitment to creating technologies that can transform patient care. The implementation of his glycosylation markers represents a step forward in understanding the complexities of cancer biology and improving diagnostic methodologies.
Collaborations
Rafael is known to collaborate with esteemed colleagues, including Raymond A. Dwek and Umi Marshida Abd Hamid. Their combined expertise contributes to a robust research environment that fosters innovation and advances the state of cancer diagnostics.
Conclusion
Rafael de Llorens stands out as an innovator in the realm of cancer diagnostics with his valuable patent on glycosylation markers. His ongoing research efforts and collaborations with leading professionals in the field further emphasize the significance of his contributions. As advancements in cancer detection continue to evolve, Rafael's work is poised to play an essential role in enhancing patient outcomes through improved diagnostic techniques.